Enovis (ENOV) Asset Writedowns and Impairment (2018 - 2025)
Enovis (ENOV) posted quarterly Asset Writedowns and Impairment of $501.3 million for Q4 2025, down 22.25% year-over-year from $644.8 million in Q4 2024, and down 8.59% quarter-over-quarter from $548.4 million in Q4 2025.
Enovis (ENOV) Asset Writedowns and Impairment (2018 - 2025) Analysis & Trends
Enovis (ENOV) has reported Asset Writedowns and Impairment for 6 consecutive years, with $501.3 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Asset Writedowns and Impairment fell 22.25% year-over-year to $501.3 million; the TTM figure through Dec 2025 stood at $1.7 billion (up 160.57% YoY), while the FY2025 annual figure was $1.0 billion, up 61.42% from the prior year.
- Asset Writedowns and Impairment retreated to $501.3 million in Q4 2025 per ENOV's latest filing, from $548.4 million in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $644.8 million in Q4 2024 and bottomed at -$67.8 million in Q2 2024.
- Historically, Asset Writedowns and Impairment has averaged $242.9 million across 3 years, with a median of $73.4 million in 2024.
- On a YoY basis, Asset Writedowns and Impairment climbed as much as 41.19% in 2024 and fell as far as 30.5% in 2024.
- Enovis' Asset Writedowns and Impairment stood at -$52.0 million in 2023, then jumped by 1340.12% to $644.8 million in 2024, then slipped by 22.25% to $501.3 million in 2025.
- Business Quant data shows ENOV's Asset Writedowns and Impairment at $501.3 million in Q4 2025, $548.4 million in Q4 2025, and $644.8 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Enovis | 1.50 Bn | 1.48 Bn | 359.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 501.31 Mn |
| Dec 31, 2025 | 501.31 Mn |
| Oct 3, 2025 | 548.44 Mn |
| Oct 3, 2025 | 548.44 Mn |
| Dec 31, 2024 | 644.75 Mn |
| Dec 31, 2024 | 644.75 Mn |
| Jun 28, 2024 | -67.85 Mn |
| Jun 28, 2024 | -67.85 Mn |
| Mar 29, 2024 | 73.40 Mn |
| Mar 29, 2024 | 73.40 Mn |
| Jun 30, 2023 | -51.99 Mn |
| Jun 30, 2023 | -51.99 Mn |
| Mar 31, 2023 | 51.99 Mn |
| Mar 31, 2023 | 51.99 Mn |
| Apr 3, 2020 | 32.00 Mn |
| Apr 3, 2020 | 32.00 Mn |
| Dec 31, 2019 | -481.00 Mn |
| Dec 31, 2019 | -481.00 Mn |
| Jun 28, 2019 | 481.00 Mn |
| Jun 28, 2019 | 481.00 Mn |